Sale!

FBXO7 Gene PARK15 Parkinson Genetic Test

Original price was: $700.Current price is: $500.

-29%

The FBXO7 Gene PARK15 Parkinson NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the FBXO7 gene associated with PARK15 Parkinson’s disease. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide detailed insights into genetic risk factors for early-onset Parkinson’s disease. The test is particularly valuable for individuals with family history of Parkinson’s or early neurological symptoms. Results help guide personalized treatment approaches and provide crucial information for family planning. The test is available for $500 USD (discounted from $700) and provides results within 3-4 weeks using blood, extracted DNA, or FTA card samples. Genetic counseling is recommended before testing to ensure proper understanding of results and implications.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

FBXO7 Gene PARK15 Parkinson NGS Genetic DNA Test

Comprehensive Genetic Testing for Parkinson’s Disease Risk

The FBXO7 Gene PARK15 Parkinson NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering individuals and families crucial insights into their genetic predisposition to Parkinson’s disease. This advanced test specifically targets mutations in the FBXO7 gene, which has been scientifically linked to PARK15, a rare form of early-onset Parkinson’s disease. Understanding your genetic risk profile can empower you to make informed healthcare decisions and take proactive steps toward better neurological health management.

What This Test Measures and Detects

This sophisticated genetic analysis utilizes Next-Generation Sequencing (NGS) technology to examine the FBXO7 gene with unprecedented accuracy and detail. The test specifically identifies:

  • Pathogenic mutations in the FBXO7 gene associated with PARK15 Parkinson’s disease
  • Single nucleotide variants (SNVs) and small insertions/deletions
  • Copy number variations affecting the FBXO7 gene region
  • Genetic markers that may influence disease progression and treatment response

The FBXO7 gene plays a critical role in protein degradation pathways within brain cells, and mutations in this gene can disrupt normal cellular function, leading to the characteristic symptoms of Parkinson’s disease.

Who Should Consider This Genetic Test

This test is particularly recommended for individuals experiencing:

  • Early-onset movement disorders or Parkinson’s-like symptoms before age 50
  • Family history of Parkinson’s disease, especially in multiple generations
  • Progressive neurological symptoms including tremors, rigidity, and bradykinesia
  • Unexplained gait disturbances or balance problems
  • Individuals planning family who have concerns about genetic inheritance
  • Patients with atypical Parkinson’s disease presentations

Significant Benefits of Genetic Testing

Undergoing the FBXO7 Gene PARK15 Parkinson NGS Genetic DNA Test provides numerous advantages:

  • Early Risk Assessment: Identify genetic predisposition before significant symptoms develop
  • Personalized Treatment Planning: Guide medication choices and therapeutic approaches based on genetic profile
  • Family Planning Insights: Understand inheritance patterns and risks for future generations
  • Reduced Diagnostic Uncertainty: Provide clarity in complex neurological cases
  • Proactive Health Management: Enable early interventions and lifestyle modifications
  • Research Contribution: Help advance scientific understanding of Parkinson’s genetics

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and neurologists. Results typically fall into three categories:

  • Positive Result: Indicates the presence of a known pathogenic mutation in the FBXO7 gene. This result suggests an increased risk for developing PARK15 Parkinson’s disease and warrants consultation with a neurologist for ongoing monitoring and management.
  • Negative Result: No known pathogenic mutations were detected in the FBXO7 gene. While this reduces the likelihood of PARK15-related Parkinson’s, it does not eliminate the possibility of other genetic or environmental factors contributing to neurological symptoms.
  • Variant of Uncertain Significance (VUS): A genetic change was identified, but its clinical significance is currently unknown. Regular follow-up and family studies may be recommended.

All results include comprehensive genetic counseling to ensure proper understanding and appropriate next steps.

Test Pricing and Availability

Test Component Price (USD)
FBXO7 Gene PARK15 Parkinson NGS Genetic DNA Test – Discount Price $500
FBXO7 Gene PARK15 Parkinson NGS Genetic DNA Test – Regular Price $700

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible testing regardless of your location.

Take Control of Your Neurological Health Today

Don’t let uncertainty about your genetic risk for Parkinson’s disease prevent you from taking proactive steps toward better health. Our comprehensive FBXO7 Gene PARK15 Parkinson NGS Genetic DNA Test provides the clarity and information you need to make informed decisions about your neurological health journey.

Call us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our dedicated team is ready to answer your questions and guide you through the testing process with compassion and expertise.

With a turnaround time of 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card, getting tested has never been more convenient. Take the first step toward understanding your genetic profile and securing your neurological future.